Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Sihuan Pharmaceutical Holdings Group Ltd
SHPHFSihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China. The company operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. It offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, and biotechnology and technology promotion services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong. Address: Office Tower, Convention Plaza, Wan Chai, Hong Kong
Analytics
WallStreetin tavoitehinta
21.3 HKDP/E-suhde
–Osinkotuotto
2.84 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut SHPHF
Osinkoanalytiikka SHPHF
Osinkojen kasvu 5 vuoden aikana
76 %Jatkuva kasvu
3 vuottaMaksusuhde 5 vuoden keskiarvo
-108 %Osinkohistoria SHPHF
Osakkeen arvostus SHPHF
Talousasiat SHPHF
Tuloksia | 2019 | Dynamiikka |